Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI

NCT07138508 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07138508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07138508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
Lead sponsor
Ain Shams University
Phase
Phase 1/2
Overall status
Completed
Start date
March 10, 2024
Completion date
March 1, 2025
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior stemi, no reflow phenomenon